Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Oct 16, 2024; 16(10): 545-556
Published online Oct 16, 2024. doi: 10.4253/wjge.v16.i10.545
Table 1 Comparison of baseline characteristics between the two groups
Characteristic
Control group (n = 260)
Study group (n = 260)
P value
GenderMale/female95/16599/1610.717
Age (years)53.01 ± 10.3752.23 ± 11.920.428
Tumor locationGastric fundus/gastric body143/117146/1140.791
Tumor long diameter6.72 ± 2.226.53 ± 2.160.320
Tumor growth patternEndoluminal/partially exophytic253/7253/7> 0.999
Tumor pathological typeLeiomyoma1611390.062
Schwannoma01> 0.999
Gastrointestinal stromal tumor991200.076
Gastrointestinal stromal tumor risk stratificationVery low risk981200.452
Low risk10
Intermediate risk00
High risk00
Table 2 Comparison of treatment results and complications between the two groups, n (%)


Control group (n = 260)
Study group (n = 260)
P value
Endoscopic treatment outcomesComplete resection (cases)260260> 0.999
Incomplete resection (cases)00> 0.999
Intraoperative complicationsIntraoperative bleeding (cases)00> 0.999
Intraoperative perforation (cases)28 (3.08)3 (1.15)< 0.001
Intraoperative endoscopic examination failure and conversion to open surgery (cases)00> 0.999
Postoperative complicationsPostoperative abdominal pain score (points)0.25 ± 0.560.16 ± 0.430.029
Postoperative delayed bleeding (cases)1 (0.38)0 (0)> 0.999
Average volume of red blood cell suspension transfused (U)200.318
Postoperative delayed perforation (cases)00 (0)> 0.999
Postoperative abdominal infection (cases)1 (0.38)0 (0)> 0.999
Postoperative respiratory tract infection (cases)3 (1.15)1 (0.38)0.624
Postoperative electrocoagulation syndrome (cases)8 (3.08)1 (0.38)0.037
Table 3 Comparison of treatment outcomes between the two groups

Control group (n = 260)
Study group (n = 260)
P value
Operative time (min)54.00 ± 9.4733.49 ± 8.46< 0.001
Length of hospital stay (d)5.04 ± 1.465.24 ± 1.450.117
Hospitalization expenses (RMB)16111.40 ± 3709.7114435.25 ± 3458.43< 0.001
Materials expenses (RMB)4115.81 ± 1486.703571.96 ± 1507.32< 0.001
Table 4 Comparison of follow-up results between the two groups

Control group (n = 260)
Study group (n = 260)
P value
Mean postoperative follow-up time (mo)3.51 ± 4.263.23 ± 4.070.457
Postoperative recurrence (cases)00> 0.999
Postoperative metastasis (cases)00> 0.999
Postoperative death (cases)00> 0.999